EXLS ExlService Holdings Inc.

EXL announces speakers for AI in Action event

EXL announces speakers for AI in Action event

Industry experts in insurance and healthcare provide real-world examples of how they use data and AI to drive business outcomes

NEW YORK, April 11, 2024 (GLOBE NEWSWIRE) -- EXL [NASDAQ: EXLS], a leading data analytics, digital operations and solutions company, announced the full agenda for its industry event, , scheduled for April 24 from 10:00 a.m. to 12:00 p.m. EDT. The event will explore how businesses are making a real impact using data and AI to reinvent business models and unlock growth.

“There are a lot of companies talking about AI right now, but this event is focused squarely on real-world results and we’ve put together an agenda that will dive deep into the specific strategies the world’s AI leaders have deployed to overcome implementation challenges and start extracting real value from AI,” said Executive Vice President and Chief Growth and Strategy Officer, Vishal Chhibbar. “Attendees will get an unprecedented look inside groundbreaking AI initiatives that are already driving outsized growth, empowering decision-making, and shaping the future of business.”

The event will showcase real-world examples of how data and AI are driving business impact at speed and scale through fireside chats, generative AI demonstrations, and industry break-out sessions with industry leaders who are driving AI transformation within their companies. The full agenda for the event includes:

Welcome and opening remarks: EXL's , will kick off the event with a preview of the agenda and introduce an exciting line-up of speakers from EXL as well as client and partner organizations. He’ll be joined by , an original member of CNBC’s Fast Money, to discuss the real-world impact of AI on business.

A keynote presentation from top executives from EXL and NVIDIA: EXL Board Chair and CEO and NVIDIA’s Senior Vice President of Enterprise Business, will discuss AI disruption and share how EXL is partnering to support clients using a data- and AI-led approach to reinventing business models - to drive better business outcomes and unlock growth with speed.

Demonstration: Enterprise ready AI platform and code translation solution: Led by EXL's President and Head of Analytics , this session will demonstrate how EXL is using its data and AI platform to help clients take advantage of generative AI technology to address specific business challenges with easily customized AI applications. Jetley will highlight how the platform enables various use cases, including showcasing EXL's code translation engine that supports data migration teams in converting databases at speed and scale as they prepare for generative AI.

An expert panel on generative AI - hype, hope and reality: Adami will analyze with industry and insurance experts, including Liberty Mutual Insurance, Chief Information Officer, ; former Chief Customer Officer at Prudential Financial, ; and EXL's President and Head of Insurance, . They will dig into the latest trends, innovations and practical business applications driving the data and AI revolution.

Demonstration: Assisting agents and buyers with EXL’s generative AI solutions: EXL's Executive Vice President and Chief Digital Officer, , will demonstrate how EXL’s smart agent assist solution that improves customer experience by providing real-time procedural guidance for the next best action for contact center staff. In addition, he will showcase EXL’s buyer assist solution which provides organizations with market data on pricing fluctuations and supply chain disruptions, real-time insights for contract negotiation, and faster paperwork processing.

An expert panel on reimagining healthcare with and AI: Adami will have a discussion with Microsoft's Global Lead for Healthcare and Life Sciences Partner Ecosystem, ; Humana's Senior Vice President and Head of Consumer and Provider Service Operations, ; EXL's Executive Vice President and Head of Healthcare, ; and Lockton's Chief Data and Analytics Officer, . The panel will cover opportunities for industry transformation with AI, including where to prioritize, implications for data, technology and operations and responsible AI with a focus on privacy, bias and governance.

Breakout sessions: explore how AI is transforming industries  

EXL’s Senior Vice President and Global Head of Growth and Acceleration, , will lead the transition to concurrent breakout sessions, where various leaders from EXL will showcase practical applications and use cases for AI across the insurance, health, banking, retail, travel, utilities and other industries.  Starting at 11:35 a.m. EDT, EXL will offer breakout sessions with demonstrations of generative AI solutions for specific industry use cases:

  • Reimagining Insurance underwriting with data and generative AI  
  • The future of Health – Reducing friction and improving experience with AI  
  • How Banks are leveraging data & AI for competitive advantage  
  • Transforming customer experience for Retail, Travel, Utilities and more  

For more information about the event, including the registration, full agenda and list of speakers, please visit the event website .

About EXL

EXL (NASDAQ: EXLS) is a leading data analytics and digital operations and solutions company. We partner with clients using a data and AI-led approach to reinvent business models, drive better business outcomes and unlock growth with speed. EXL harnesses the power of data, analytics, AI, and deep industry knowledge to transform operations for the world’s leading corporations in industries including insurance, healthcare, banking and financial services, media and retail, among others. EXL was founded in 1999 with the core values of innovation, collaboration, excellence, integrity and respect. We are headquartered in New York and have more than 54,000 employees spanning six continents. For more information, visit .

Cautionary Statement Regarding Forward-Looking Statements

This press release contains forward-looking statements within the meaning of the United States Private Securities Litigation Reform Act of 1995. You should not place undue reliance on those statements because they are subject to numerous uncertainties and factors relating to EXL's operations and business environment, all of which are difficult to predict and many of which are beyond EXL’s control. Forward-looking statements include information concerning EXL’s possible or assumed future results of operations, including descriptions of its business strategy. These statements may include words such as “may,” “will,” “should,” “believe,” “expect,” “anticipate,” “intend,” “plan,” “estimate” or similar expressions. These statements are based on assumptions that we have made in light of management's experience in the industry as well as its perceptions of historical trends, current conditions, expected future developments and other factors it believes are appropriate under the circumstances. You should understand that these statements are not guarantees of performance or results. They involve known and unknown risks, uncertainties and assumptions. Although EXL believes that these forward-looking statements are based on reasonable assumptions, you should be aware that many factors could affect EXL’s actual financial results or results of operations and could cause actual results to differ materially from those in the forward-looking statements. These factors, which include our ability to maintain and grow client demand, our ability to hire and retain sufficiently trained employees, and our ability to accurately estimate and/or manage costs, rising interest rates, rising inflation and recessionary economic trends, are discussed in more detail in EXL’s filings with the Securities and Exchange Commission, including EXL’s Annual Report on Form 10-K. You should keep in mind that any forward-looking statement made herein, or elsewhere, speaks only as of the date on which it is made. New risks and uncertainties come up from time to time, and it is impossible to predict these events or how they may affect EXL. EXL has no obligation to update any forward-looking statements after the date hereof, except as required by federal securities laws.

© 2024 ExlService Holdings, Inc.  All rights reserved. For more information go to 

Contacts

Media

Keith Little



Investor Relations

John Kristoff





EN
11/04/2024

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on ExlService Holdings Inc.

 PRESS RELEASE

EXL Reports 2024 First Quarter Results

EXL Reports 2024 First Quarter Results 2024 First Quarter Revenue of $436.5 Million, up 9.0% year-over-yearQ1 Diluted EPS (GAAP) (1) of $0.29, down 3.3% from $0.30 in Q1 of 2023Q1 Adjusted Diluted EPS (Non-GAAP) (1) (2) of $0.38, up 8.9% from $0.35 in Q1 of 2023 NEW YORK, May 02, 2024 (GLOBE NEWSWIRE) -- ExlService Holdings, Inc. (NASDAQ: EXLS), a leading data analytics and digital operations and solutions company, today announced its financial results for the quarter ended March 31, 2024. Rohit Kapoor, Chairman and Chief Executive Officer, said, “We are pleased with our first quart...

Wedbush Research
  • Wedbush Research
2454 MEDIATEK INC.
LOGN LOGITECH INTERNATIONAL S.A.
VMW VMWARE INC. CLASS A
QRVO QORVO INC.
XNCR XENCOR INC.
XENE XENON PHARMACEUTICALS INC
WDC WESTERN DIGITAL CORPORATION
VYGR VOYAGER THERAPEUTICS INC.
TSLA TESLA INC
SIMON SILICON MOTION TECHNOLOGY CORPORATION SPONSORED ADR
SGMO SANGAMO THERAPEUTICS INC.
SBUX STARBUCKS CORPORATION
RWT REDWOOD TRUST INC.
RARE ULTRAGENYX PHARMACEUTICAL INC.
QCOM QUALCOMM INC
PSTG PURE STORAGE INC. CLASS A
PCRX PACIRA BIOSCIENCES INC.
NVDA NVIDIA CORPORATION
NVCR NOVOCURE LTD.
NTAP NETAPP INC.
NBIX NEUROCRINE BIOSCIENCES INC.
MU MICRON TECHNOLOGY INC.
MCD MCDONALD'S CORPORATION
KURA KURA ONCOLOGY INC.
KPTI KARYOPHARM THERAPEUTICS
INTC INTEL CORPORATION
GOOGL ALPHABET INC. CLASS A
GERN GERON CORP.
FTNT FORTINET INC.
FATE FATE THERAPEUTICS INC
EXLS EXLSERVICE HOLDINGS INC.
EAT BRINKER INTERNATIONAL INC.
DENN DENNY'S CORPORATION
CTMX CYTOMX THERAPEUTICS INC.
CMRX CHIMERIX INC
BPMC BLUEPRINT MEDICINES CORP.
BMRN BIOMARIN PHARMACEUTICAL INC.
BIIB BIOGEN INC.
AXTI AXT INC.
ARDX ARDELYX INC
SWKS SKYWORKS SOLUTIONS INC.
FRX_CN FENNEC PHARMACEUTICALS
2330 TAIWAN SEMICONDUCTOR MANUFACTURING CO. LTD.
2303 UNITED MICROELECTRONICS CORP.
TMHC TAYLOR MORRISON HOME CORPORATION
HPE HEWLETT PACKARD ENTERPRISE CO.
TWTR TWITTER INC.
UTHR UNITED THERAPEUTICS CORPORATION
CLSD CLEARSIDE BIOMEDICAL INC
ALBO ALBIREO PHARMA
ANAB ANAPTYSBIO INC.
KALA KALA PHARMACEUTICALS INC.
ARGX ARGENX ADS
MRSN MERSANA THERAPEUTICS
GTHX G1 THERAPEUTICS
ALPN ALPINE IMMUNE SCIENCES
AMZN AMAZON.COM INC.
AMD ADVANCED MICRO DEVICES INC.
AAPL APPLE INC.
MSFT MICROSOFT CORPORATION
IBM INTERNATIONAL BUSINESS MACHINES CORPORATION
APLS APELLIS PHARMACEUTICALS
DNLI DENALI THERAPEUTICS INC
RCUS ARCUS BIOSCIENCES
AVGO BROADCOM INC.
HEAR TURTLE BEACH CORP.
SURF SURFACE ONCOLOGY
SRRK SCHOLAR ROCK HOLDING CORPORATION
KNSA KINIKSA PHARMACEUTICALS
LQDA LIQUIDIA CORPORATION
REPL REPLIMUNE GROUP
AX AXOS FINANCIAL INC.
ARVN ARVINAS HOLDING
YMAB Y-MABS THERAPEUTICS
STRO SUTRO BIOPHARMA
PINS PINTEREST INC. CLASS A
BCEL ATRECA
DELL DELL TECHNOLOGIES INC CLASS C
STOK STOKE THERAPEUTICS
IGMS IGM BIOSCIENCES
SWTX SPRINGWORKS THERAPEUTICS
LC LENDINGCLUB CORP
SMCI SUPER MICRO COMPUTER
AQST INC.
IDYA AQUESTIVE THERAPEUTICS
PASG IDEAYA BIOSCIENCES
BDTX PASSAGE BIO
ACET BLACK DIAMOND THERAPEUTICS
CRSR ADICET BIO INC
ITOS CORSAIR GAMING
ZNTL ITEOS THERAPEUTICS
PRAX ZENTALIS PHARMACEUTICALS
FUBO PRAXIS PRECISION MEDICINES
TVTX FUBOTV
LSEA TRAVERE THERAPEUTICS INC
VRDN LANDSEA HOMES CORP (A)
DAWN VIRIDIAN THERAPEUTICS INC
ELEV DAY ONE BIOPHARMACEUTICALS INC
OMGA ELEVATION ONCOLOGY
LBPH OMEGA THERAPEUTICS
THRX LONGBOARD PHARMACEUTICALS
MRVL THESEUS PHARMACEUTICALS
STX INC.
DSGN MARVELL TECHNOLOGY INC
ATXS SEAGATE TECHNOLOGY HLDGS PLC
AVTE DESIGN THERAPEUTICS INC
GFS ASTRIA THERAPEUTICS INC
RLYB AEROVATE THERAPEUTICS INC
KRTX GLOBALFOUNDRIES INC
FUSN RALLYBIO CORP
VIGL KARUNA THERAPEUTICS INC
EWTX FUSION PHARMACEUTICALS INC
VIGIL NEUROSCIENCE INC
EDGEWISE THERAPEUTICS INC
 PRESS RELEASE

EXL announces speakers for AI in Action event

EXL announces speakers for AI in Action event Industry experts in insurance and healthcare provide real-world examples of how they use data and AI to drive business outcomes NEW YORK, April 11, 2024 (GLOBE NEWSWIRE) -- EXL [NASDAQ: EXLS], a leading data analytics, digital operations and solutions company, announced the full agenda for its industry event, , scheduled for April 24 from 10:00 a.m. to 12:00 p.m. EDT. The event will explore how businesses are making a real impact using data and AI to reinvent business models and unlock growth. “There are a lot of companies talking about AI ...

 PRESS RELEASE

EXL Schedules First Quarter 2024 Financial Results Conference Call; An...

EXL Schedules First Quarter 2024 Financial Results Conference Call; Announces Investor Strategy Update Event NEW YORK, April 10, 2024 (GLOBE NEWSWIRE) -- ExlService Service Holdings, Inc. (NASDAQ: EXLS), a leading data analytics and digital operations and solutions company, will host a conference call to announce financial results for the first quarter ended March 31, 2024, on Thursday, May 2, 2024, before the market opens. The company will host a conference call at 10:00 a.m. EDT on Thursday, May 2, 2024, with Board Chair and Chief Executive Officer Rohit Kapoor and Executive Vice Presi...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch